Submitted: 07 January 2026 You are already at the latest version Background/Objectives: Repetitive magnetic stimulation (rMS) and static magnetic stimulation (sMS) are currently used as adjunctive therapies for certain neurological conditions. Despite substantial advances in cancer treatment, unfavorable prognoses and outcomes persist, especially for aggressive neoplasms, including glioblastoma and acute myeloid leukemia.